Sarcoma Clinical Trials
Narrow List by Age:
(Refer to Clinical Summary for age requirements)
Sarcoma
| Protocol | Alliance A091902 |
|---|---|
| Cancer Type: | ANGIOSARCOMA |
A MULTICENTER PHASE II TRIAL OF PACLITAXEL WITH AND WITHOUT NIVOLUMAB IN TAXANE NAÏVE, AND NIVOLUMAB AND CABOZANTINIB IN TAXANE PRETREATED SUBJECTS WITH ANGIOSARCOMA
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | COG ARST1431 |
|---|---|
| Cancer Type: | IR Rhabdomyosarcoma |
| Fast Facts |
A Randomized Phase III Study of Vincristine, Dactinomycin, Cyclophosphamide (VAC) Alternating With Vincristine and Irinotecan (VI) Versus VAC/VI Plus Temsirolimus (TORI, Torisel, NSC# 683864) in Patients With Intermediate Risk (IR) Rhabdomyosarcoma (RMS)
Feasibility Phase: Patients must be < 21 Years of Age at the Time of Enrollment.
Efficacy Phase: Patients must be ≤ 40 Years of Age at the Time of Enrollment.
| Protocol | COG ALTE16C1 |
|---|---|
| Cancer Type: | Sarcoma |
| Fast Facts |
Effects of Modern Chemotherapy Regimens on spermatogenesis and Steroidogenesis in Adolescent and Young Adult (AYA) Survivors of Osteosarcoma
Patients must be ≥ 18 and ≤ 50 Years of Age at the Time of Enrollment
Please check out the rare protocol list to locate other studies within this disease site.
Cancer clinical trials are research studies for developing better ways of detecting,
treating, and eventually preventing cancer. By taking part in a clinical trial,
you are among the first to receive new research treatments before they are widely
available. Your participation in a clinical trial will influence the future direction
of cancer care.
If you are interested in participating in a clinical trial, consult with your physician.
Please note: clinical trials are not risk free. Patients must explore the options
that are best for their individuals needs with the help of their physician.
